Case Study
Global Pharmaceutical Leader Achieves Simplified End User Experience
elluminate Powers their Next-Generation Clinical Research Data Repository and Analytics Platform
Background
Conducting global clinical research trials requires data management and analysis technology that can accommodate a variety of users from data conversion to medical review. For study activities to run smoothly, all users need to be able to access and interact with study data as easily as possible. Siloed data and disjointed user experiences lead to unnecessarily high query rates and can slow things down considerably. After receiving feedback from many of internal teams that a legacy data platform was no longer supporting the needs of modern trials, one leading global pharmaceutical company decided to seek more specific feedback in order to address concerns, be future ready for higher volume and velocity data and move forward with selecting a new and better data repository and analytics solution.
The Challenge
The company deployed a multi-pronged initiative to gain insights from the widest possible sampling of its platform users. This included a mix of one-on-one interviews with more than 30 users representing varied types of stakeholders from all over the world. They supplemented this with an email survey seeking broader feedback from more than 100 additional users. Questions sought users’ thoughts on the existing platform as well as asking for what kinds of features they would like in a “perfect” solution.
The team then created a list of user personas which included research scientists, data curators, medical data reviewers, data conversion experts and data analysts. User journey maps were then created for each persona with survey data used to create models for ideal user experiences.
Company Profile
■ Top 25 Ranked Pharmaceutical Company in Revenue
■ Headquartered in Europe
■ 60K+ Employees
Products Utilized
Data Central Mapper
Clinical Analytics
Selecting the Best Fit Solution
With the feedback received, the desired user experiences mapped out and 20+ possible partners evaluated, the pharma company selected the elluminate Clinical Data Cloud to help all its users access, analyze and interact with the data more easily. They needed a system that would enable trial stakeholders with efficient and user-friendly solutions for managing and leveraging data. The system needed to also allow them to maximize the use of both internal and external data, providing room for additional innovation with future research projects. This meant that any solution would need to be flexible enough to allow for the company’s evolving stance on outsourcing as they moved
The Results
from full outsourcing to more of a functional service provider (FSP) model. Whether they were taking in raw data or data from a contract research organization (CRO), they needed a platform solution that could function well in either scenario.
By implementing eClinical Solution’s elluminate, the global pharma company was able to handle both the primary and secondary use of clinical research data for submissions and exploratory analysis. Through elluminate, users would be able to request, receive, validate, transform, integrate and analyze data, all from one place. This allows them to unlock more value from its scientific data through deeper insights that help guide more informed, agile decision-making.
While still early in the implementation phase, the pharma company has already seen a number of user experience improvements with its new data platform, such as:
■ One consistent data flow supporting both insourced and outsourced trials
■ Simplified, intuitive user interfaces across teams for real-time data integration, curation and harmonization
■ Interoperability with other clinical research data technologies
■ Easy data access for appropriate use and better decision-making
■ Traceability for optimized oversight, auditing and knowledge management
■ Flexibility to explore data freely while maintaining data preservation and security
■ ‘Plug and play’ analytical tools to transform data into evidence or input data from different sources
By choosing to implement elluminate, the pharmaceutical company is now ready to move forward with a truly next-generation data repository and analytics platform. Through engaging end users and building detailed user journey maps, the company was able to select the best solution to help them deliver better, simplified user experiences. By making data management and analysis easier for users, the company is making significant progress toward its goal of conducting more efficient clinical trials.
For more information, please visit us at: eclinicalsol.com
Or email us at: info@eclinicalsol.com